The Efficacy of Vildagliptin Concomitant With Insulin Therapy in Type 2 Diabetic Subjects

BACKGROUND: In Japan, dipeptidyl peptidase 4 (DPP4) inhibitors have become standard therapeutic agents for type 2 diabetes, and numbers of patients receiving insulin therapy combined with DPP4 inhibitors, which is a highly effective regimen, are increasing. METHODS: In this study, we evaluated the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Daisuke, Inoue, Kazuyuki, Kaneko, Kimie, Yanagisawa, Morifumi, Sumita, Takashi, Ikegami, Yuichi, Awata, Takuya, Ishida, Hitoshi, Katayama, Shigehiro, Inukai, Kouichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356089/
https://www.ncbi.nlm.nih.gov/pubmed/25780477
http://dx.doi.org/10.14740/jocmr2057w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356089/
https://www.ncbi.nlm.nih.gov/pubmed/25780477
http://dx.doi.org/10.14740/jocmr2057w

Ejemplares similares